HOME >> MEDICINE >> NEWS
Passing stop sign cures gene disease

awbacks. The body absorbs it poorly, so it must be injected or inhaled. And inhaling is fine for cystic fibrosis, but of little use for conditions such as muscular dystrophy. The antibiotic can also cause rare but serious side effects such as hearing loss and kidney damage.

That's where PTC124 comes in: it was designed from the start to have similar properties to gentamicin but to be safer and more easily absorbed. "We are really in a different situation now, where we are trying to identify drugs based on how they should act," says Langdon Miller, chief medical officer of PTC Therapeutics in New Jersey.

The drug was screened out of a pool of 175,000 synthetic molecules. Pre-clinical tests so far indicate that it is more potent than gentamicin and seems to have very low toxicity. "This could have very far-reaching effects," claims David Bedwell, a microbiologist at the University of Alabama in Birmingham, who has tested the compound in his lab and is collaborating with the company.

In mice with muscular dystrophy the drug restores expression of the dystrophin protein found on the surface of muscle cells. Tests suggest the muscles regain some of their normal characteristics. Tests on mice with cystic fibrosis also suggest PTC124 restores production of functional CFTR.

All the results remain unpublished, though researchers working with the company say they hope to publish as soon as intellectual property issues are resolved. Miller says the company hopes to start clinical trials with healthy volunteers as early as next year.

But a premature stop mutation will not always be the cause of a particular genetic disease. So even if PTC124 or gentamicin make it to the market for treating genetic diseases, they will not be a magical cure for everyone.


'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
15-Oct-2003


Page: 1 2

Related medicine news :

1. Procedure cures atrial fibrillation
2. First UK cases of previously rare disease reported in gay men
3. Uric acid and heart disease
4. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
5. Risky surgery not always necessary to treat cervical disease
6. Stanford patient is first to test new treatment for peripheral arterial disease
7. Community care tops medical care at preventing heart disease in black Americans
8. Neuronal death and processing of Tau protein in Alzheimers disease
9. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
10. Reducing hostility in young coronary artery disease patients is important piece of rehabilitation
11. Study finds direct association between cardiovascular disease and periodontal bacteria

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Passing stop sign cures gene disease

(Date:5/27/2015)... Pasadena, California (PRWEB) May 27, 2015 ... were marked by a few historic firsts -- and ... at the Pasadena Civic Center marked the first time ... and the first time a Graduate College of Biomedical ... Medicine of the Pacific (COMP). , The university’s fifth ...
(Date:5/27/2015)... May 27, 2015 “We are honored ... MD, executive vice president and vice president of clinical ... makes possible allows us to provide comprehensive care to ... community.” , SSCHC provides clinical care and behavioral health ... people in 2014, many of whom took advantage of ...
(Date:5/27/2015)... While hair transplantation has been used successfully ... study conducted by a physician member of the International ... follicle grafting can help treat patients with non-healing chronic ... ISHRS, which offers research grants for the purpose of ... In the past decade, numerous scientific studies have corroborated ...
(Date:5/27/2015)... 27, 2015 NOVAtime Technology, Inc. ... Management solutions for enterprise organizations, announced today that ... to automate its time, attendance and point tracking ... in the United States. , Family-owned since ... of 21 retail, private label, and mill brands. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The MedSpa ... three FDA-approved dermal filler treatments in Abilene, Texas: Xeomin®, ... reduce the appearance of glabellar lines, better known as ... Belotero Balance® is designed to treat smoker’s lines around ... the chin, while Radiesse® improves the appearance of smile ...
Breaking Medicine News(10 mins):Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
(Date:5/27/2015)... May 27, 2015 ... du décalage horaire. Il nuit sérieusement à ... concentration durant les réunions de mi-journée et ... au mauvais moment dans votre chambre d,hôtel. ... décalage horaire risque de vous empêcher de ...
(Date:5/27/2015)... 27, 2015 The report " Tube Packaging ... & Oral Care, Food & beverages, Pharmaceuticals, Consumer Goods), by ... Region - Trends & Forecasts to 2020", published by MarketsandMarkets, ... at a CAGR of 6.65% from 2015, to reach $8,638.9 ... data Tables and   61 F igures spread thro ...
(Date:5/27/2015)... May 25, 2015 Research and Markets( ... "2015 Strategies in the US Flow Cytometry ... This report presents a comprehensive analysis of the ... issues pertaining to the French flow cytometry practice, ... and technological trends with significant market impact during ...
Breaking Medicine Technology:HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 4Tube Packaging Market Worth $8.63 Billion by 2020 2Tube Packaging Market Worth $8.63 Billion by 2020 3Tube Packaging Market Worth $8.63 Billion by 2020 42015 Strategies in the US Flow Cytometry Market 2
Cached News: